{
  "kind": "explainer",
  "discoverable": true,
  "related": [
    {
      "slug": "vaccine-schedule",
      "label": "Childhood schedules",
      "reason": "Why timing and local guidance matter."
    },
    {
      "slug": "vaccine-ingredients",
      "label": "Vaccine ingredients",
      "reason": "Check product-specific amounts and evidence."
    },
    {
      "slug": "vaccines",
      "label": "Vaccines overall",
      "reason": "Other disease-prevention examples."
    }
  ],
  "id": "newborn-hepatitis-b-protection",
  "slug": "newborn-hepatitis-b",
  "title": "Hepatitis B vaccination protects babies from serious liver disease",
  "summary": "Babies can catch hepatitis B during birth or through infected blood. Infection in infancy is especially likely to become chronic. Vaccination prevents infection, and a birth dose provides early protection. Countries differ on which babies receive it at birth.",
  "keyPoints": [
    {
      "text": "Newborns can be exposed during birth or through infected blood.",
      "sources": [
        1,
        2
      ]
    },
    {
      "text": "Early infection is much more likely to become long-lasting than infection in adulthood.",
      "sources": [
        1
      ]
    },
    {
      "text": "Long-term research shows that early vaccination can prevent liver cancer.",
      "sources": [
        3
      ]
    }
  ],
  "evidence": [
    {
      "id": "infant-transmission",
      "heading": "Babies can acquire the infection",
      "text": "Hepatitis B can pass during childbirth and through infected blood or certain body-fluid exposure. Sex is not the only route; ordinary social contact does not spread it. Infection acquired in infancy is especially likely to persist and cause later liver disease.",
      "sources": [
        1,
        2
      ],
      "detailTopics": [],
      "sourceIds": [
        "vaccine-update-b1",
        "vaccine-update-b2"
      ]
    },
    {
      "id": "birth-dose",
      "heading": "The birth dose provides a safety net",
      "text": "Early vaccination helps address missed maternal infection, screening or documentation problems and early household exposure. A negative maternal test matters and lowers identified risk; it does not make every exposure impossible. Maternal status, birth weight and clinical circumstances can change timing.",
      "sources": [
        2
      ],
      "detailTopics": [
        "vaccine-schedule"
      ],
      "sourceIds": [
        "vaccine-update-b2"
      ]
    },
    {
      "id": "liver-protection",
      "heading": "Early prevention protects the liver over decades",
      "text": "The Qidong trial’s 30-year follow-up found less liver cancer after neonatal vaccination. It took place in a part of China where hepatitis B was common, with few cancer events and follow-up limits. It does not directly compare birth with two months for a reliably screened, low-risk US infant.",
      "sources": [
        3
      ],
      "detailTopics": [],
      "sourceIds": [
        "vaccine-update-b3"
      ]
    },
    {
      "id": "hepb-safety",
      "heading": "Safety and side effects",
      "text": "A large historical California study found no association between birth immunization and neonatal death after cause review. Crude group differences do not show protection against every neonatal death. Local pain and short-lived symptoms can occur; severe allergy is rare.",
      "sources": [
        4,
        5
      ],
      "detailTopics": [
        "vaccine-ingredients"
      ],
      "quickLink": "Safety and side effects",
      "sourceIds": [
        "vaccine-update-b4",
        "vaccine-update-b5"
      ]
    },
    {
      "id": "hepb-policy",
      "heading": "Countries organize early protection differently",
      "text": "England combines routine infant vaccination with a targeted birth-dose pathway for exposed babies. Universal and targeted programs are different policy choices; neither implies babies cannot acquire hepatitis B. Checked 15 October 2026: the CDC index links its July 2, 2025 US child schedule. Use current official guidance and individual medical advice, not an isolated older policy announcement.",
      "sources": [
        1,
        2,
        6,
        7,
        8
      ],
      "detailTopics": [],
      "sourceIds": [
        "vaccine-update-b1",
        "vaccine-update-b2",
        "vaccine-update-l1",
        "vaccine-update-b6",
        "vaccine-update-b6-targeted"
      ]
    }
  ],
  "sources": [
    {
      "id": "vaccine-update-b1",
      "title": "Hepatitis B",
      "publisher": "WHO",
      "url": "https://www.who.int/news-room/fact-sheets/detail/hepatitis-b",
      "readerBlurb": "Explains transmission, chronic infection and global prevention; individual risk and national programs differ.",
      "limit": "Explains transmission, chronic infection and global prevention; individual risk and national programs differ.",
      "access": "Mapped to the 14 October 2026 research archive; selected fresh checks and access limits recorded in output/live-review/vaccine-content/independent-source-review.md.",
      "revision": "research-2026-10-15",
      "retrievedAt": "2026-10-14",
      "locale": "en",
      "type": "Evidence source",
      "geographicCoverage": {
        "kind": "undetermined",
        "countryCodes": [],
        "jurisdictionCodes": [],
        "note": "Explains transmission, chronic infection and global prevention; individual risk and national programs differ."
      },
      "publicationTitle": "Hepatitis B",
      "archiveDate": "2026-10-14",
      "supports": [
        "Babies can acquire the infection",
        "Countries organize early protection differently"
      ],
      "limitationsInternal": [
        "Mapped to the 14 October 2026 research archive; selected fresh checks and access limits recorded in output/live-review/vaccine-content/independent-source-review.md.",
        "Explains transmission, chronic infection and global prevention; individual risk and national programs differ."
      ],
      "limitationsPublic": [
        "Explains transmission, chronic infection and global prevention; individual risk and national programs differ."
      ]
    },
    {
      "id": "vaccine-update-b2",
      "title": "Prevention of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices",
      "publisher": "CDC, 2018",
      "url": "https://www.cdc.gov/mmwr/volumes/67/rr/rr6701a1.htm",
      "readerBlurb": "Explains the birth-dose safety net and clinical exceptions; historical recommendations require a current schedule check.",
      "limit": "Explains the birth-dose safety net and clinical exceptions; historical recommendations require a current schedule check.",
      "access": "Mapped to the 14 October 2026 research archive; selected fresh checks and access limits recorded in output/live-review/vaccine-content/independent-source-review.md.",
      "revision": "research-2026-10-15",
      "retrievedAt": "2026-10-14",
      "locale": "en",
      "type": "Evidence source",
      "geographicCoverage": {
        "kind": "undetermined",
        "countryCodes": [],
        "jurisdictionCodes": [],
        "note": "Explains the birth-dose safety net and clinical exceptions; historical recommendations require a current schedule check."
      },
      "publicationTitle": "Prevention of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices",
      "archiveDate": "2026-10-14",
      "supports": [
        "Babies can acquire the infection",
        "The birth dose provides a safety net",
        "Countries organize early protection differently"
      ],
      "limitationsInternal": [
        "Mapped to the 14 October 2026 research archive; selected fresh checks and access limits recorded in output/live-review/vaccine-content/independent-source-review.md.",
        "Explains the birth-dose safety net and clinical exceptions; historical recommendations require a current schedule check."
      ],
      "limitationsPublic": [
        "Explains the birth-dose safety net and clinical exceptions; historical recommendations require a current schedule check."
      ]
    },
    {
      "id": "vaccine-update-b3",
      "title": "Long-term efficacy of neonatal hepatitis B vaccination against hepatocellular carcinoma and other liver diseases: a 30-year follow-up study of the Qidong hepatitis B intervention study",
      "publisher": "PLOS Medicine, 2014",
      "url": "https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1001774",
      "readerBlurb": "Cluster-randomized trial in high-endemicity China; not a birth-versus-two-months trial in low-risk US infants.",
      "limit": "Cluster-randomized trial in high-endemicity China; not a birth-versus-two-months trial in low-risk US infants.",
      "access": "Mapped to the 14 October 2026 research archive; selected fresh checks and access limits recorded in output/live-review/vaccine-content/independent-source-review.md.",
      "revision": "research-2026-10-15",
      "retrievedAt": "2026-10-14",
      "locale": "en",
      "type": "Evidence source",
      "geographicCoverage": {
        "kind": "undetermined",
        "countryCodes": [],
        "jurisdictionCodes": [],
        "note": "Cluster-randomized trial in high-endemicity China; not a birth-versus-two-months trial in low-risk US infants."
      },
      "publicationTitle": "Long-term efficacy of neonatal hepatitis B vaccination against hepatocellular carcinoma and other liver diseases: a 30-year follow-up study of the Qidong hepatitis B intervention study",
      "archiveDate": "2026-10-14",
      "supports": [
        "Early prevention protects the liver over decades"
      ],
      "limitationsInternal": [
        "Mapped to the 14 October 2026 research archive; selected fresh checks and access limits recorded in output/live-review/vaccine-content/independent-source-review.md.",
        "Cluster-randomized trial in high-endemicity China; not a birth-versus-two-months trial in low-risk US infants."
      ],
      "limitationsPublic": [
        "Cluster-randomized trial in high-endemicity China; not a birth-versus-two-months trial in low-risk US infants."
      ]
    },
    {
      "id": "vaccine-update-b4",
      "title": "Lack of association between hepatitis B birth immunization and neonatal death: a population-based study from the vaccine safety datalink project",
      "publisher": "Pediatric Infectious Disease Journal, 2004",
      "url": "https://pubmed.ncbi.nlm.nih.gov/15247605/",
      "readerBlurb": "Historical California birth cohort with cause review; crude group differences do not prove protection from all neonatal deaths.",
      "limit": "Historical California birth cohort with cause review; crude group differences do not prove protection from all neonatal deaths.",
      "access": "Mapped to the 14 October 2026 research archive; selected fresh checks and access limits recorded in output/live-review/vaccine-content/independent-source-review.md.",
      "revision": "research-2026-10-15",
      "retrievedAt": "2026-10-14",
      "locale": "en",
      "type": "Evidence source",
      "geographicCoverage": {
        "kind": "undetermined",
        "countryCodes": [],
        "jurisdictionCodes": [],
        "note": "Historical California birth cohort with cause review; crude group differences do not prove protection from all neonatal deaths."
      },
      "publicationTitle": "Lack of association between hepatitis B birth immunization and neonatal death: a population-based study from the vaccine safety datalink project",
      "archiveDate": "2026-10-14",
      "supports": [
        "Safety and side effects"
      ],
      "limitationsInternal": [
        "Mapped to the 14 October 2026 research archive; selected fresh checks and access limits recorded in output/live-review/vaccine-content/independent-source-review.md.",
        "Historical California birth cohort with cause review; crude group differences do not prove protection from all neonatal deaths."
      ],
      "limitationsPublic": [
        "Historical California birth cohort with cause review; crude group differences do not prove protection from all neonatal deaths."
      ]
    },
    {
      "id": "vaccine-update-b5",
      "title": "Hepatitis B Vaccine Safety",
      "publisher": "CDC",
      "url": "https://www.cdc.gov/vaccine-safety/vaccines/hepatitis-b.html",
      "readerBlurb": "Summarizes vaccine reactions and safety studies.",
      "limit": "Summarizes vaccine reactions and safety studies.",
      "access": "Mapped to the 14 October 2026 research archive; selected fresh checks and access limits recorded in output/live-review/vaccine-content/independent-source-review.md.",
      "revision": "research-2026-10-15",
      "retrievedAt": "2026-10-14",
      "locale": "en",
      "type": "Evidence source",
      "geographicCoverage": {
        "kind": "undetermined",
        "countryCodes": [],
        "jurisdictionCodes": [],
        "note": "Summarizes vaccine reactions and safety studies."
      },
      "publicationTitle": "Hepatitis B Vaccine Safety",
      "archiveDate": "2026-10-14",
      "supports": [
        "Safety and side effects"
      ],
      "limitationsInternal": [
        "Mapped to the 14 October 2026 research archive; selected fresh checks and access limits recorded in output/live-review/vaccine-content/independent-source-review.md.",
        "Summarizes vaccine reactions and safety studies."
      ],
      "limitationsPublic": [
        "Summarizes vaccine reactions and safety studies."
      ]
    },
    {
      "id": "vaccine-update-l1",
      "title": "Child and Adolescent Immunization Schedule by Age (Compliant)",
      "publisher": "CDC",
      "url": "https://www.cdc.gov/vaccines/hcp/imz-schedules/child-adolescent-age-compliant.html",
      "readerBlurb": "Current published US schedule and court-status notice; national policy is separate from biological safety evidence.",
      "limit": "Current published US schedule and court-status notice; national policy is separate from biological safety evidence.",
      "access": "Mapped to the 14 October 2026 research archive; selected fresh checks and access limits recorded in output/live-review/vaccine-content/independent-source-review.md.",
      "revision": "research-2026-10-15",
      "retrievedAt": "2026-10-14",
      "locale": "en",
      "type": "Evidence source",
      "geographicCoverage": {
        "kind": "undetermined",
        "countryCodes": [],
        "jurisdictionCodes": [],
        "note": "Current published US schedule and court-status notice; national policy is separate from biological safety evidence."
      },
      "publicationTitle": "Child and Adolescent Immunization Schedule by Age (Compliant)",
      "archiveDate": "2026-10-14",
      "supports": [
        "Countries organize early protection differently"
      ],
      "limitationsInternal": [
        "Mapped to the 14 October 2026 research archive; selected fresh checks and access limits recorded in output/live-review/vaccine-content/independent-source-review.md.",
        "Current published US schedule and court-status notice; national policy is separate from biological safety evidence."
      ],
      "limitationsPublic": [
        "Current published US schedule and court-status notice; national policy is separate from biological safety evidence."
      ]
    },
    {
      "id": "vaccine-update-b6",
      "title": "A guide to immunisations for babies up to 13 months of age",
      "publisher": "UK Health Security Agency",
      "url": "https://www.gov.uk/government/publications/a-guide-to-immunisations-for-babies-up-to-13-months-of-age/a-guide-to-immunisation-for-babies-up-to-13-months-of-age-for-children-born-on-or-after-1-july-2024",
      "readerBlurb": "England combines routine infant immunization with a separate targeted pathway for babies exposed to hepatitis B.",
      "limit": "England combines routine infant immunization with a separate targeted pathway for babies exposed to hepatitis B.",
      "access": "Mapped to the 14 October 2026 research archive; selected fresh checks and access limits recorded in output/live-review/vaccine-content/independent-source-review.md.",
      "revision": "research-2026-10-15",
      "retrievedAt": "2026-10-14",
      "locale": "en",
      "type": "Evidence source",
      "geographicCoverage": {
        "kind": "undetermined",
        "countryCodes": [],
        "jurisdictionCodes": [],
        "note": "Explains transmission, chronic infection and global prevention; individual risk and national programs differ."
      },
      "publicationTitle": "A guide to immunisations for babies up to 13 months of age",
      "archiveDate": "2026-10-14",
      "supports": [
        "Countries organize early protection differently"
      ],
      "limitationsInternal": [
        "Mapped to the 14 October 2026 research archive; selected fresh checks and access limits recorded in output/live-review/vaccine-content/independent-source-review.md.",
        "England combines routine infant immunization with a separate targeted pathway for babies exposed to hepatitis B."
      ],
      "limitationsPublic": [
        "England combines routine infant immunization with a separate targeted pathway for babies exposed to hepatitis B."
      ]
    },
    {
      "id": "vaccine-update-b6-targeted",
      "title": "Protecting your baby against hepatitis B with the hepatitis B vaccine",
      "publisher": "UK Health Security Agency",
      "url": "https://www.gov.uk/government/publications/protecting-your-baby-against-hepatitis-b-leaflet/protecting-your-baby-against-hepatitis-b-with-the-hepatitis-b-vaccine",
      "readerBlurb": "England’s targeted pathway for babies exposed at birth; not a universal world schedule.",
      "limit": "England’s targeted pathway for babies exposed at birth; not a universal world schedule.",
      "access": "Mapped to the 14 October 2026 research archive; selected fresh checks and access limits recorded in output/live-review/vaccine-content/independent-source-review.md.",
      "revision": "research-2026-10-15",
      "retrievedAt": "2026-10-14",
      "locale": "en",
      "type": "Evidence source",
      "geographicCoverage": {
        "kind": "undetermined",
        "countryCodes": [],
        "jurisdictionCodes": [],
        "note": "Explains transmission, chronic infection and global prevention; individual risk and national programs differ."
      },
      "publicationTitle": "Protecting your baby against hepatitis B with the hepatitis B vaccine",
      "archiveDate": "2026-10-14",
      "supports": [
        "Countries organize early protection differently"
      ],
      "limitationsInternal": [
        "Mapped to the 14 October 2026 research archive; selected fresh checks and access limits recorded in output/live-review/vaccine-content/independent-source-review.md.",
        "England’s targeted pathway for babies exposed at birth; not a universal world schedule."
      ],
      "limitationsPublic": [
        "England’s targeted pathway for babies exposed at birth; not a universal world schedule."
      ]
    }
  ],
  "dossier": "vaccine-narratives-major-2026-10-14.md",
  "limits": [
    "The findings apply to the vaccines, populations and outcomes studied. Personal recommendations depend on your health and current local guidance."
  ],
  "scope": "",
  "takeaway": "Babies can catch hepatitis B during birth or through infected blood.",
  "contextTitle": "",
  "contextIntro": "",
  "detail": "",
  "revision": "vaccine-2026-10-15",
  "researchDate": "2026-10-14",
  "copyReviewedAt": "2026-10-15",
  "locale": "en",
  "topic": "Vaccines",
  "tag": "Newborn hepatitis B",
  "assessment": "Source-grounded explanation · research draft",
  "geographicScope": {
    "kind": "global",
    "countryCodes": [],
    "jurisdictionCodes": [],
    "note": "Evidence and jurisdiction limits are stated beside the relevant claims."
  },
  "reviewNeeds": "Independent clinical/editorial approval remains pending; no personalized schedule.",
  "updateTriggers": "New studies, corrected sources, regulatory safety signals and changed local recommendations.",
  "readerCopyEdition": "vaccine-clarity-2026-10-15",
  "questions": [],
  "questionsHeading": "Find the answer you need",
  "headline": {
    "text": "Hepatitis B vaccination protects babies from serious liver disease",
    "revision": 1,
    "status": "draft",
    "sourceMessageId": null,
    "approvedAt": null,
    "authority": "15 October 2026 authorized vaccine implementation; source-mapped editorial brief. Agent review is not clinical or owner approval."
  },
  "language": "en",
  "jurisdiction": {
    "kind": "global",
    "countryCodes": [],
    "jurisdictionCodes": [],
    "note": "Evidence and jurisdiction limits are stated beside the relevant claims."
  },
  "claimScope": "",
  "research": {
    "dossierRef": "docs/research/vaccine-narratives-major-2026-10-14.md",
    "reviewedAt": "2026-10-14",
    "reviewDue": "New studies, corrected sources, regulatory safety signals and changed local recommendations.",
    "contraryEvidenceConsidered": [],
    "status": "research draft; editorial/context review separate"
  },
  "status": "researched draft preview",
  "realWorldClaimReviewed": false,
  "clinicalEditorialApproved": false
}